STEPHANIE GRASKY: Open Payments
NPI 1386833366 · TUCSON, AZ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,024 in 123 payments from 24 companies in 2025. Trend: 2023 $1,511 · 2024 $1,525 · 2025 $2,024
Food & beverage: $2,024
| Company | Payments | Amount |
|---|---|---|
| GlaxoSmithKline, LLC. | 29 | $422 |
| AstraZeneca Pharmaceuticals LP | 13 | $322 |
| Amgen Inc. | 24 | $285 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 9 | $138 |
| Merck Sharp & Dohme LLC | 4 | $97 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 6 | $90 |
| Exact Sciences Corporation | 5 | $85 |
| Bayer Healthcare Pharmaceuticals Inc. | 5 | $78 |
| Novo Nordisk Inc | 4 | $66 |
| PFIZER INC. | 3 | $49 |
Products named: TRELEGY ELLIPTA, OTEZLA, SHINGRIX, CAPLYTA, FARXIGA, AIRSUPRA, EVENITY, XIFAXAN.
Industry payments across AZ — which companies pay providers there.
